QA: Carisma Therapeutics Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2021_Carisma_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc.

  xvar xval
0 AssetsCurrent 62,867,000
1 IntangibleAssetsNetIncludingGoodwill 59,464,000
2 PropertyPlantAndEquipmentNet 123,000
3 remainder_Assets 369,000
4 LiabilitiesCurrent 18,049,000
5 LiabilitiesNoncurrent 1,618,000
6 remainder_Liabilities 112,383,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,302,000
9 ResearchAndDevelopmentExpense 29,191,000
10 remainder_Expenses -9,735,000
11 remainder_Revenues 11,236,000
12 remainder_NetIncome 125,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 122,823,000
1 Liabilities 132,050,000
2 Expenses 33,758,000
3 Revenues 11,236,000
4 StockholdersEquity -9,227,000
5 NetIncome -22,397,000
6 ComprehensiveNetIncome -22,397,000
7 BaseVar 149,996,000
8 EconomicCapitalRatio -0.300

Edgar->Model Mapping

Feature Distribution

Change over Time